Cat. No.: DAB-0011772
| Product Information | |
|---|---|
| Clonality | Polyclonal |
| Host Species | Rabbit |
| Reactivity | Human, Monkey |
| Applications | WB, IP |
| Product Description | Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Pro338 of human arginase-2 protein. Antibodies are purified by protein A and peptide affinity chromatography. |
| Format | Liquid |
| Purity | Affinity purity |
| Target Information | |
|---|---|
| Target Name | ARG2 |
| UniProt No. | P78540 |
| Gene ID | 384 |
| Gene Description | Arginase-2 is a mitochondrial enzyme that catalyzes the hydrolysis of L-arginine to L-ornithine and urea. Research studies have shown that in acute myeloid leukemia patients, arginase-2 is released from AML blasts to the plasma, leading to the suppression of T-cell proliferation. It was also shown that arginase-2 is required for the immunosuppressive properties of neonatal CD71 erythroid cells, which inhibits neonatal host defense against infection. In addition, the expression of arginase-2 in dendritic cells is repressed by microRNA-155 during maturation. This repression is essential for T-cell activation and response. |
| Shipping & Storage | |
|---|---|
| Shipping | Shipped at 4 °C. |
| Storage Instructions | Store at –20 °C. Do not aliquot the antibody. |
| Storage Buffer | Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/ml BSA and 50% glycerol. |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
